Anton Klingler

Safety and immunogenicity of a Vero-cell-derived, inactivated Japanese encephalitis vaccine: a non-inferiority, phase III, randomised controlled trial

Erich Tauber, Herwig Kollaritsch, Maria Korinek et al. · The Lancet · 2007 · 192 citations

Vaccinology, Vaccine Safety, Vaccination +6

Single-shot live-attenuated chikungunya vaccine in healthy adults: a phase 1, randomised controlled trial

Nina Wressnigg, Romana Hochreiter, Oliver Zoihsl et al. · The Lancet Infectious Diseases · 2020 · 98 citations

Vaccination, Vaccine Safety, Vaccinology +7

Efficacy, immunogenicity, and safety of IC43 recombinant Pseudomonas aeruginosa vaccine in mechanically ventilated intensive care patients—a randomized clinical trial

Christopher Adlbrecht, Raphael Wurm, Pieter Depuydt et al. · Critical Care · 2020 · 76 citations · Full text

A randomized placebo-controlled phase II study of a Pseudomonas vaccine in ventilated ICU patients

Jordi Rello, Krenn Claus-Georg, Gottfried J. Locker et al. · Critical Care · 2017 · 75 citations · Full text

Safety profile of the Vero cell-derived Japanese encephalitis virus (JEV) vaccine IXIARO®

Elisabeth Schuller, Anton Klingler, Katrin Dubischar-Kastner et al. · Vaccine · 2011 · 46 citations

Vaccination, Vaccine Safety, Vaccine Ixiaro® +8